Biotechnology: Fueling Innovation and Job Creation, Transforming Care The U.S. produces more new drugs than the rest of the world combined*
U.S. bioscience firms employ 1.7 million people in communities across the country.**
Switzerland
13%
US
Japan
8%
57%
8%
*Source: Milken Institute; Xconomy, “Which Countries Excel in Creating New Drugs? It’s Complicated” 2014; Kneller, Nature Biotechnology, 2012
UK
6% 6%
**Source: “The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life 2016” BIO/TEConomy (includes health care, agriculture and industrial and environmental jobs)
Germany France
Percentages do not add up to 100% due to rounding.
U.S. is well-positioned for future innovation U.S. headquartered firms are responsible for more than 60% of current worldwide clinical programs conducted by emerging biotechnology companies. These trials will drive future medical breakthroughs and economic growth.
61.4%
13.2%
ld or
Re
st
of
st
W
ra
lia
y Au
an rm
n
ce
Ge
an Fr
pa Ja
l
da na Ca
ae Isr
nd
Sw
itz
er
la
UK
US
5.0% 4.1% 3.3% 3.0% 2.7% 2.7% 2.7% 2.0%
Source: BioMedTracker, BIO Industry Analysis
drugcostfacts.org
U.S. LEADERSHIP IN BIOTECHNOLOGY
Effective Public Policy is Critical to Maintaining Leadership and Long-Term Success To maintain U.S. leadership, the policy and regulatory environment needs to keep pace with innovations happening in labs across the country. The only thing that can impede long-term U.S. biotechnology leadership is short sighted policy proposals that stifle innovation and scare away investment. Entrepreneurs and investors need policy certainty to be successful at the incredibly difficult task of drug development, where more than 90% of endeavors fail.
THE U.S. HAS…
THE U.S. NEEDS TO MAINTAIN…
Brilliant scientists
Transparent payment systems that reward innovation and encourage free-market competition
Savvy entrepreneurs
World-class research institutions
Investors willing to commit the capital needed to fund medical innovation
“
An efficient and predictable regulatory review process
Continued advancement and funding of scientific understanding
Strong intellectual property (IP) rights and a reliable system for IP transfer, licensing, and collaboration
Creating new drugs through biotechnology is at the risky end of a business in which superhuman stamina and bottomless pockets are minimum requirements. — The Economist Magazine
Biotechnology: Fueling Innovation and Job Creation, Transforming ...
U.S. LEADERSHIP IN BIOTECHNOLOGY drugcostfacts.org. Biotechnology: Fueling Innovation and Job Creation,. Transforming Care. The U.S. produces more new drugs than the rest of the world combined*. U.S. headquartered firms are responsible for more than. 60% of current worldwide clinical programs conducted by.
emerging biotechnology companies. These trials will ... (includes health care, agriculture and industrial and environmental jobs). Switzerland. US. UK. Japan.
Israel. Canada. Japan. France. Germany Australia. Rest of W orld. U.S. is well-positioned for future innovation. Percentages do not add up to 100% due to ...
Sep 21, 2010 - ... York, NY 10045. Phone: 212-720-7339. Email: [email protected]. .... The benchmark model does not include hiring subsidies and the ...
Nov 1, 2017 - protecting and promoting access to resources for comprehensive pain and addiction treatment. 3. STIMULATE RESEARCH & DEVELOPMENT (R&D) OF INNOVATIVE. TREATMENTS THAT EFFECTIVELY TREAT PAIN AND OPIOID. ADDICTION AND PREVENT ABUSE. ⢠In
The biopharmaceutical industry has the highest percentage of R&D reinvestment of any U.S. industry. Small, emerging companies are at the forefront of the ...
makes positive contributions to global food production and food security. ... house gas emissions while lessening the need for insecticides and pesticides.
companies are at the forefront of the search for new cures and therapies, ... of biopharmaceutical companies are not profitable. ... Internet Software/Services.
retention, reduced pesticide runoff, and reduced greenhouse gas emissions. New developments help American farmers produce crops that use water more effi-.
Mar 1, 2017 - nutritional ingredients as well as flavors and fragrances; and. ⢠enzymes, which are used in household cleaners, laundry detergents, and ... Biomaterials, Biochemicals, Industrial Enzymes), By Application (Bioenergy, Food & Feed. Addi
The Biotechnology Industry Organization (BIO) appreciates the opportunity to .... the pace at which production of recently invented goods shifts to the South both increase. ...... reasonable terms, as determined by the Department of Health.
description of a patent shall disclose the invention in a manner sufficiently .... Other nations include a patent term extension to compensate for the time it takes to.
Oct 8, 2014 - and look for future posts in the series. Imagine how your day might look in the workplace of the future. Your computer knows your face (it's how you log in); it responds ... Unified communications with HD audio and video (complete with
Oct 8, 2014 - personal computing device by simply sitting there, without the need for any wires. Even better, your computer becomes the assistant you never ...
An example of successful social entrepreneurship is micro-credit financing. ..... This gap in growth highlights a trend to privatization of government social services. ..... Encourage government support of social enterprise by developing a shared.
of potential jobs, there is a zero-profit condition for a new job vacancy that can produce the most highly valued ... implied by the matching law and rational non-cooperative behaviour by individual workers and employers. ..... therefore, the net ret
BIOMEDICAL INNOVATION CAN HELP SOLVE THE OPIOID CRISIS. Opioid addiction is plaguing communities across the country, leaving in its wake countless victims, devastated families and economic ruin. Long-term solutions to combating this crisis will depen